轻松健康 02661Prospectus Information

Prospectus Information
返回 Stock Info Prospectus Allotment Results Allotment Profile Expected Lots
IPO Timeline
Broker Deadline
2025-12-18
Morning deadline
HKEX Deadline
2025-12-18
Noon deadline
Broker Results (T-2)
2025-12-19
Some brokers release in afternoon
Grey Market (T-1)
2025-12-22
Afternoon
HKEX Allotment (T-1)
2025-12-22
Evening
Registrar Allotment (T-1)
2025-12-22
Evening
Listing Day (T)
2025-12-23
First day of trading
Company Overview
Stock Name轻松健康
Stock Code02661
Company Full Name轻松健康
IndustryHealthcare
Principal Activities我们于中国提供健康相关及保险相关解决方案。根据沙利文报告的资料，按2024年的收入计，我们于中国数字综合健康服务及健康保险服务市场排名第10位。具体而言，根据同一资料来源，按2024年的收入计，我们在中国数字健康服务市场排名第七。我们致力于通过一套易用、精准且可负担的健康解决方案，为有需要的人提供保障和支持。
Listing Date2025-12-23
Listing Rules EraNew Rules (after Aug 2025)
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市東城區安定門東大街28號雍和大廈F座7層
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websiteqingsonghealth.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo
Offering Information
Offering Mechanism Mechanism B
Offer PriceHK$ 22.68 / shares
Offer Price RangeFinal offer price only, no range
Lot Size200 shares
Entry ThresholdHK$ 4,536
Par ValueRMB 0.0001 / shares
Offer Period2025-12-15 to 2025-12-18
Global Offering Shares2,654,000 shares
HK Public Offer Shares (Initial)2,654,000 shares (100.0%)
Public Offer Lots (Initial)13,270lots (6,635lots, 6,635lots)
International Placing Shares (Initial)23,886,000 shares (0.0%)
Offer Ratio~100.0%
Total Shares Post-IPO206,374,209 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share0%
Clawback Tiers机制B：无回补机制
Reallocation OptionNo
Total Global Offering SizeHK$ 60,192,720
Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 200 HK$ 4,536
2 lots 400 HK$ 9,072
3 lots 600 HK$ 13,608
4 lots 800 HK$ 18,144
5 lots 1,000 HK$ 22,680
6 lots 1,200 HK$ 27,216
7 lots 1,400 HK$ 31,752
8 lots 1,600 HK$ 36,288
9 lots 1,800 HK$ 40,824
10 lots 2,000 HK$ 45,360
15 lots 3,000 HK$ 68,040
20 lots 4,000 HK$ 90,720
25 lots 5,000 HK$ 113,400
30 lots 6,000 HK$ 136,080
35 lots 7,000 HK$ 158,760
40 lots 8,000 HK$ 181,440
45 lots 9,000 HK$ 204,120
50 lots 10,000 HK$ 226,800
100 lots 20,000 HK$ 453,600
150 lots 30,000 HK$ 680,400
200 lots 40,000 HK$ 907,200
250 lots 50,000 HK$ 1,134,000
500 lots 100,000 HK$ 2,268,000
750 lots 150,000 HK$ 3,402,000
1,000 lots 200,000 HK$ 4,536,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,250 lots 250,000 HK$ 5,670,000
1,500 lots 300,000 HK$ 6,804,000
1,750 lots 350,000 HK$ 7,938,000
2,000 lots 400,000 HK$ 9,072,000
2,250 lots 450,000 HK$ 10,206,000
2,500 lots 500,000 HK$ 11,340,000
2,750 lots 550,000 HK$ 12,474,000
3,000 lots 600,000 HK$ 13,608,000
3,500 lots 700,000 HK$ 15,876,000
4,000 lots 800,000 HK$ 18,144,000
4,500 lots 900,000 HK$ 20,412,000
5,000 lots 1,000,000 HK$ 22,680,000
5,500 lots 1,100,000 HK$ 24,948,000
6,000 lots 1,200,000 HK$ 27,216,000
6,635 lots 1,327,000 HK$ 30,096,360
Valuation & Financials
Market Cap (at Offer Price)HK$ 4,680,000,000
Pre-IPO Valuation (Last Round)To be extracted
P/E Ratio不适用（公司处于亏损状态）
Profit/Loss Status盈利约人民币9.0百万元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 88,500,000
Listing Expenses / Funds Raised~14.7%
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 58.7
First Day OpenHK$ 50.0
First Day Change158.82%
First Day Volume6239600.0
First Day Turnover320167000.0
Use of Proceeds
Use of Proceeds1、約40.0%或205.4百萬港元，將用于提升品牌知名度、提高用戶參與度及加強與業務合作伙伴的合作； 2、約20.0%或102.7百萬港元，將用于醫學研究和真實世界研究； 3、約20.0%或102.7百萬港元，將用于提升在AI及大數據領域的技術能力，以便更廣泛應用于產品及服務； 4、約10.0%或51.3百萬港元，將用于拓展至更多地區及海外市場； 5、約10.0%或51.3百萬港元，用作營運資金及其他一般公司用途。
Underwriting Syndicate
Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894 招商证券（香港）有限公司 CE AAI650
Overall Coordinators (2)
中国国际金融香港证券有限公司 CE AEN894 招商证券（香港）有限公司 CE AAI650
Joint Global Coordinators (3)
中国国际金融香港证券有限公司 CE AEN894 招商证券（香港）有限公司 CE AAI650 富途证券国际（香港）有限公司 CE AZT137
Joint Bookrunners (4)
中国国际金融香港证券有限公司 CE AEN894 招商证券（香港）有限公司 CE AAI650 富途证券国际（香港）有限公司 CE AZT137 浦银国际融资有限公司 CE BFZ375
Joint Lead Managers (4)
中国国际金融香港证券有限公司 CE AEN894 招商证券（香港）有限公司 CE AAI650 富途证券国际（香港）有限公司 CE AZT137 浦银国际融资有限公司 CE BFZ375
Capital Market Intermediaries (4)
中国国际金融香港证券有限公司 CE AEN894 招商证券（香港）有限公司 CE AAI650 富途证券国际（香港）有限公司 CE AZT137 浦银国际融资有限公司 CE BFZ375
Service Providers
RoleInstitution
Legal Advisor to Company 贝克‧麦坚时律师事务所
天元律师事务所
衡力斯律师事务所
通商律师事务所
Legal Advisor to Sponsors/Underwriters 史密夫斐尔律师事务所
海问律师事务所
Auditor and Reporting Accountant 德勤‧关黄陈方会计师行
Industry Advisor 弗若斯特沙利文（北京）咨询有限公司上海分公司
Receiving Banks 招商永隆银行有限公司
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 中金资本为中国国际金融股份有限公司 — — — — 6 months 2026-06-23
2 中国国际金融香港证券有限公司 — — — — 6 months 2026-06-23
Directors & Management
Chairman杨胤
Company Secretary楊磊,陳靜雅
執行董事 (2)
#NameEnglish NameType
1 杨胤 — 執行董事
2 王静 — 執行董事
非執行董事 (3)
#NameEnglish NameType
1 赵宇平 — 非執行董事
2 郑凯还 — 非執行董事
3 吴彬 — 非執行董事
獨立非執行董事 (3)
#NameEnglish NameType
1 王晓燕 — 獨立非執行董事
2 周耀明 — 獨立非執行董事
3 白昆 — 獨立非執行董事
Major Shareholders
Major Shareholders & Holdings杨胤女士通过QingSongChou Holdings Corporation、Yang Group Holdings Limited、Yang Group Holdings Limited等实体控制公司约20.58%的股份（假设超额配股权未获行使）。其他主要股东包括阳光人寿保险股份有限公司（约7.74%）、德同环球消费投资有限公司（约3.04%）、TDH Venture Capital Investment Limited（约6.19%）等。
AI AI Analysis
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO saw extreme demand with an oversubscription ratio of 1421.47x, reflecting intense market enthusiasm. The hit rate of 11.03% underscores the fierce competition for allocations. The offer price was fixed at HKD 22.68, though no initial range is available for comparison. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

A striking tier inefficiency exists: the 甲尾 (200,000 lots) expected only 0.0687 lots, while the 乙头 (250,000 lots) received a higher 0.1562 expected lots, making the 甲尾 tier disproportionately unfavorable. This inversion suggests that larger B-tier applications gained a significant allocation advantage. Broker fee efficiency would likely favor the B-tier, though actual costs depend on individual fee structures. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic data appears incomplete, with reported total holders, mainland participation, and Hong Kong participation all at zero. Consequently, no analysis of investor geography or profile is possible for this IPO. This absence limits any assessment of regional demand dynamics. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

AI-generated content. For informational purposes only. Not financial advice. Verify against official sources.
Offering Structure
Subscription Tiers
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics